Drug Shortage Report for SANDOZ MIRTAZAPINE
Report ID | 62941 |
Drug Identification Number | 02250608 |
Brand name | SANDOZ MIRTAZAPINE |
Common or Proper name | MIRTAZAPINE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | MIRTAZAPINE |
Strength(s) | 30MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100S |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-08-24 |
Estimated end date | 2018-11-23 |
Actual end date | 2018-11-26 |
Shortage status | Resolved |
Updated date | 2018-11-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-11-27 | English | Compare |
v7 | 2018-11-26 | French | Compare |
v6 | 2018-11-26 | English | Compare |
v5 | 2018-10-30 | French | Compare |
v4 | 2018-10-30 | English | Compare |
v3 | 2018-10-30 | English | Compare |
v2 | 2018-10-02 | French | Compare |
v1 | 2018-10-02 | English | Compare |
Showing 1 to 8 of 8